Literature DB >> 7152092

Effects of thyroid hormones on the ontogeny of oestradiol-binding sites in the rat.

G Barbanel, I Assenmacher.   

Abstract

The effects of neonatal hypothyroidism on the development of cytoplasmic oestradiol-binding sites were studied in the hypothalamus, pituitary and uterus of the rat. Between 7 and 28 days the total number of binding sites was significantly reduced in all three tissues, whereas the actual concentrations of binding sites were dramatically depressed throughout the period considered in the pituitary only. Adequate replacement therapy by L-thyroxine almost completely reversed all these effects in 14-day-old rats, and administration of excessive L-thyroxine even raised pituitary binding-site concentrations to above normal. On the other hand, plasma oestrogen levels, which were depressed in hypothyroid animals, fell even further, whatever the L-thyroxine therapy. Hence, thyroid hormones appear to stimulate oestradiol binding-site levels directly rather than indirectly via plasma oestrogen titres. The specific modulatory effect of L-thyroxine on oestradiol-binding sites in various types of pituitary cells is discussed.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7152092     DOI: 10.1016/0303-7207(82)90124-1

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  3 in total

1.  Effects of thyroxine on the ontogeny of the vitellogenic response in Pleurodeles waltli of both sexes.

Authors:  Christian Cayrol; Pierre Deparis
Journal:  Rouxs Arch Dev Biol       Date:  1987-04

2.  Long term effects of neonatal hypothyroidism on pituitary estradiol binding sites in the female rat.

Authors:  G Barbanel; I Assenmacher
Journal:  Experientia       Date:  1983-11-15

3.  Hormonal influence on the secretory immune system of the eye: endocrine interactions in the control of IgA and secretory component levels in tears of rats.

Authors:  D A Sullivan; M R Allansmith
Journal:  Immunology       Date:  1987-03       Impact factor: 7.397

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.